{"cmr":"uk-cm-kg/AIM/STX","since":null,"total":54,"cursor":0,"limit":50,"next_cursor":50,"events":[{"cmr":"uk-cm-kg/AIM/STX","date":"2026-11-03","event_type":"financial_statement","title":"Q3 2026 Trading Update","rns_category":"Q3 2026 Trading Update","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/q3-2026-trading-update-/9854489","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Wre1PLKG1K0oqhvZkpPvIn0_euvX2UBI3mcyWvpRdzWU__jpsKJXneBh4PXV66DEGPnkmMZ4Mnn5whsCtkQ9Bg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-10-30","event_type":"ch_capital","title":"capital allotment shares — 2026-10-21","ch_filing_type":"capital","source":"Companies House","url":"https://find-and-update.company-information.service.gov.uk/company/09761509/filing-history/MzU1MzY0MjI1NWFkaXF6a2N4/document?format=pdf&download=0","read_by":"Companies House REST API (filing history)","detail":"form SH01; category capital","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"0HKjmYw6gdsCTL6XGXaymYbeFGtcBM-y1uOs5IMsXDmHn-ADmkReiV3wY5vWacyaEbcVmzcUJ_2OGHvXVGamCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-10-30","event_type":"corporate_action","title":"Total Voting Rights","rns_category":"Total Voting Rights","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/total-voting-rights/9851075","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ZIBhD9eQL_uazR-ix79vch_mOxsN6p4MwM3xMwKgVRbZvLmIYyfaYHx1JvVGFHS95uaawYKjfJHkdk_7F_CuAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-10-23","event_type":"ch_other","title":"legacy","ch_filing_type":"miscellaneous","source":"Companies House","url":"https://find-and-update.company-information.service.gov.uk/company/09761509/filing-history/MzU1MjE3ODQ0N2FkaXF6a2N4/document?format=pdf&download=0","read_by":"Companies House REST API (filing history)","detail":"form RP01SH01; category miscellaneous","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"X_cWTO4EoOP4nqkH8rdcn3Afmka4y0miOQAU3BPmluHMUZLvfpqQoaRaQ0oDL7cySlxOGvImAdrPUycDFw-iAg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-10-23","event_type":"ch_other","title":"legacy","ch_filing_type":"miscellaneous","source":"Companies House","url":"https://find-and-update.company-information.service.gov.uk/company/09761509/filing-history/MzU1MjE3Nzc2M2FkaXF6a2N4/document?format=pdf&download=0","read_by":"Companies House REST API (filing history)","detail":"form RP01SH01; category miscellaneous","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"0K76235nsgzC4G8is3VFQjpEbTiYy44I4qHjxsWIpIc_URkT7RDZ9yXt1plcn9LRmfKLafh9PefoZmvgVvHuAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-10-08","event_type":"ch_confirmation_statement","title":"confirmation statement with no updates — 2026-09-02","ch_filing_type":"confirmation statement","source":"Companies House","url":"https://find-and-update.company-information.service.gov.uk/company/09761509/filing-history/MzU0OTg2MTU3NWFkaXF6a2N4/document?format=pdf&download=0","read_by":"Companies House REST API (filing history)","detail":"form CS01; category confirmation-statement","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Na9yMUP7QcqEH_tmmpPqFepy_5dMEpoZYYLyteEeJADC01hErfn8T2rwAonBRzbv86GAbPCMJV1maNR0F2O-BA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-09-01","event_type":"corporate_action","title":"Total Voting Rights","rns_category":"Total Voting Rights","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/total-voting-rights/9747165","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"doRlryGSMaqn04go-Q7PgSxj2wC0tFoqagS-boMqiaXRfV0_BT3--LfC2za-cv6koUDrXg-fI6fiG_vtt5kmDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-08-27","event_type":"regulatory_announcement","title":"Shield assumes full control of ACCRUFeR® in the US","rns_category":"Shield assumes full control of ACCRUFeR® in the US","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/shield-assumes-full-control-of-accrufer-in-the-us/9744178","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"eKR5RiOCsgvCMBc5j1tYrmrGyEQcOAU7bS-FWAOMf6irraG1lL0CnNy2r1xTnarOWREnAQnSiPucd8_cWPLWCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-08-20","event_type":"financial_statement","title":"Interim results for the six months ended 30 Jun 26","rns_category":"Interim results for the six months ended 30 Jun 26","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/interim-results-for-the-six-months-ended-30-jun-26/9730759","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"_aTqXxFjn83higkuhVCkaD7C0ICkXaPxuDcZ2AZQoJrtFrIYVDbCChHE--wuWHdMiW4hFMRNw9WuD6-hw8uICw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-08-03","event_type":"ch_capital","title":"capital allotment shares — 2026-08-03","ch_filing_type":"capital","source":"Companies House","url":"https://find-and-update.company-information.service.gov.uk/company/09761509/filing-history/MzUzNjY1NjM0N2FkaXF6a2N4/document?format=pdf&download=0","read_by":"Companies House REST API (filing history)","detail":"form SH01; category capital","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"SiVjpECLmchhDgzkLnp_lIgXV5iLuF0P7FossfSjt1zoXjjDWfdKr9PO4gTKowEc59RScaS_756lg0h6AjPACw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-08-03","event_type":"corporate_action","title":"Total Voting Rights","rns_category":"Total Voting Rights","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/total-voting-rights/9701490","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Bjun-TTWnaTarTFUMEzkou2ruoRy2ZiDZhgR05i1oasRdfdzcgNYNMPVg20mQm9K92Afj8VQ5hEu9H9jKNhWAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-07-30","event_type":"financial_statement","title":"Q2 and H1 2026 Trading Update","rns_category":"Q2 and H1 2026 Trading Update","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/q2-and-h1-2026-trading-update/9694692","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"xJCJKPAbx5fQ1FsbEewTExj0w0Jlu3OpZ215kVHLZXtDzYIF2o9V4_UQs9-gC4syqNjeIux8SwbkPwmvUEvXBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-07-28","event_type":"regulatory_announcement","title":"ACCRUFeR® Phase 3 pediatric trial published","rns_category":"ACCRUFeR® Phase 3 pediatric trial published","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/accrufer-phase-3-pediatric-trial-published/9689968","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"EnGY6mu70_cMWmZXIxpigvcu0W64WfAP_2uTU_GPL5Vl8kvPTa-pFIxIENhcJY67n5lkN_33Ffwk9HcEh4PNAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-07-02","event_type":"ch_resolution","title":"resolution","ch_filing_type":"resolution","source":"Companies House","url":"https://find-and-update.company-information.service.gov.uk/company/09761509/filing-history/QUY0TEFQTVlhZGlxemtjeA/document?format=pdf&download=0","read_by":"Companies House REST API (filing history)","detail":"form RESOLUTIONS; category resolution","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ua8l-qpYIoHiJgOsj4oRobrHpxSLm7Df6XXcnPdpMxsDGkp6WLUAqDB15lguPmPrfkD3LiHU83cz68kI3Q7PBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-06-30","event_type":"corporate_action","title":"Block Listing 6 Monthly Return","rns_category":"Block Listing 6 Monthly Return","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/block-listing-6-monthly-return-/9643821","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"icZHwpb_5hx8r15AIQtOJ3d2QegcR0rn3w6xH0h7NkFBtjN_X8mz7QxQFZydiGu97IjyZLhyf4XQuqTAR5paBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-06-29","event_type":"ch_capital","title":"capital allotment shares — 2026-06-29","ch_filing_type":"capital","source":"Companies House","url":"https://find-and-update.company-information.service.gov.uk/company/09761509/filing-history/MzUyOTE4MjEyMGFkaXF6a2N4/document?format=pdf&download=0","read_by":"Companies House REST API (filing history)","detail":"form SH01; category capital","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"lVyx9II3vzQ3KPTe0fdf0md7quYM_NCgPGpWbPRRQ5a3fd-D1Blf5NvB5nbiI59P-UF85TEcdfw1RuLzFLrsDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-06-18","event_type":"agm_record_date","title":"Results of 2026 Annual General Meeting","rns_category":"Results of 2026 Annual General Meeting","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/results-of-2026-annual-general-meeting/9626189","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"o7ez8yWufYaeqVdVXWBExFWAj2Z_YTSZOXAVxOA4h6nJqD8Vd-HlnrtYQTtyI2g69KfAdWrTieZm18uo3wYsDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-05-29","event_type":"ch_accounts_filed","title":"accounts with accounts type group — 2025-12-31","ch_filing_type":"accounts","source":"Companies House","url":"https://find-and-update.company-information.service.gov.uk/company/09761509/filing-history/MzUyMzIyOTc4N2FkaXF6a2N4/document?format=pdf&download=0","read_by":"Companies House REST API (filing history)","detail":"form AA; category accounts","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"mU9dkeRpku6pYiocHZtH6OAT26jsx86roQiMcbW791O6Bn78K2MRgxTgSqOTkUpgHh0mb9t4Fh64jUyNe1phBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-05-29","event_type":"corporate_action","title":"Total Voting Rights","rns_category":"Total Voting Rights","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/total-voting-rights/9591972","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"BwIIo8Ff3Y3pfJ8sM67RHQYuKLK9X7BXAJo9C2abHXF-iM_GrQZ5Pfou07wnVpNBkg1p9MQpSErPIMjOhqNKDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-05-28","event_type":"ch_capital","title":"capital allotment shares — 2026-05-20","ch_filing_type":"capital","source":"Companies House","url":"https://find-and-update.company-information.service.gov.uk/company/09761509/filing-history/MzUyNDExMzIyNWFkaXF6a2N4/document?format=pdf&download=0","read_by":"Companies House REST API (filing history)","detail":"form SH01; category capital","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"tgfBvof2vu9I7l_H1YcTmA4nfJrSjRznHwBgT_tlicti8nHIVrftRPOJyDyaazH1DMvsXMkp5lIXspBzf0PJDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-05-05","event_type":"regulatory_announcement","title":"Grant of Share Options","rns_category":"Grant of Share Options","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/grant-of-share-options/9550736","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"814OLwvS5uFDM5VySU6XHLQqwsjV1GnbrbA2AIGdOaIY7bRE1Z7snN1Xq2WME37W4rE55HubJtyx__NaPSDgBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-05-01","event_type":"financial_statement","title":"Q1 2026 Trading Update","rns_category":"Q1 2026 Trading Update","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/q1-2026-trading-update-/9547945","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"xFVaEbvarXxOk3YXMmIjMnVwNroPPqrOYu9VgnSpMcDfYWpK1BmMcK7V63J8uGLtGm-RiaXxryKKmwt8nTw_DQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-04-30","event_type":"corporate_action","title":"Total Voting Rights","rns_category":"Total Voting Rights","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/total-voting-rights/9545478","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"15AjPVVPixR_3OmvqZB7JCvxnNGIkn1upgI7CtBLPu-ZZumL1MAQE5XeVEUCF5-TrHYMKcQwWDaoVlRJPhPZDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-04-27","event_type":"regulatory_announcement","title":"Enrollment in Phase II Clinical Trial for ACCRUFeR","rns_category":"Enrollment in Phase II Clinical Trial for ACCRUFeR","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/enrollment-in-phase-ii-clinical-trial-for-accrufer/9538206","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"DvzoCcASqrH7b8DnqRa3b4LoLHrBXs9ZIRtym320vP0roqBTPy8INq1rsbWEGCG5AhKxvrMXz3XmPJOEGpM7Bg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-04-09","event_type":"financial_statement","title":"Audited results for year ended 31 December 2025","rns_category":"Audited results for year ended 31 December 2025","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/audited-results-for-year-ended-31-december-2025/9513012","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"dFto6VqOKEtoljzzQ9NGa5_R70Y0LXLtPsfDxJWLe9svuODSX1_RkHdlI-9excJbxI2wU_JZmka4ZjW-kl4yBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-04-01","event_type":"regulatory_announcement","title":"Publication of Report, Reinforcing FDA Approval","rns_category":"Publication of Report, Reinforcing FDA Approval","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/publication-of-report-reinforcing-fda-approval-/9502978","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"iwQC0w4tkFYaEe1_7_FMVafJBSquo7eLqdBNqKYgMTrXaou5QgN7rbOM90JB-Xv91Y5xwOqVGB5n7l0FQp8uBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-03-31","event_type":"corporate_action","title":"Total Voting Rights","rns_category":"Total Voting Rights","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/total-voting-rights/9499489","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"Rq4pnRPrxyuj6dYT2VSu95OqfptlU2IlDxEPvroqPRe5VSlM0TR2TCevPj7YWp6Xdk-8Wb_OuWSHe_8Wux4cBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-03-31","event_type":"regulatory_announcement","title":"EMA approves extension - to include adolescents","rns_category":"EMA approves extension - to include adolescents","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/ema-approves-extension-to-include-adolescents-/9499260","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"CB6lDAL_p7pCAOV7lO336qD5ehhrMmrQTXOG1pmJbB00wnUApPEvz-WaPoUR4SSg8fU_5XlfOv1Ne5pg6XnqDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-03-03","event_type":"regulatory_announcement","title":"Chinese NMPA Accepts MAA Submission for ACCRUFeR®","rns_category":"Chinese NMPA Accepts MAA Submission for ACCRUFeR®","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/chinese-nmpa-accepts-maa-submission-for-accrufer-/9454749","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"14yvw5S0g6dyDGqoJ9-nTFo-9I2-dzKa6DQo05-c5byGxSaVMAek1jVTkMhXgwND0kguZpGz-XRGY6OuYOd9AA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-02-27","event_type":"corporate_action","title":"Total Voting Rights","rns_category":"Total Voting Rights","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/total-voting-rights/9449869","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"s1e0BmQeOvs1jQangae4ZHu207wblsXil5CMCHVrjUn4Aavv92Zdv73G-tlcsdQjjlkkAFi_ZB3jdVzAk6Z6DQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-02-20","event_type":"ch_capital","title":"capital allotment shares — 2026-01-28","ch_filing_type":"capital","source":"Companies House","url":"https://find-and-update.company-information.service.gov.uk/company/09761509/filing-history/MzUwNjM1MDU2NmFkaXF6a2N4/document?format=pdf&download=0","read_by":"Companies House REST API (filing history)","detail":"form SH01; category capital","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"rzHkg0Q7_AxWS5x_b3Q3UefReE_YJxO7rYv0eRkCfY65KHIBwY-eYSSi0AAZtHExmk7t63lKQYQNkBhwBBqgAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-02-09","event_type":"regulatory_announcement","title":"FDA Grants additional Exclusivity for ACCRUFeR","rns_category":"FDA Grants additional Exclusivity for ACCRUFeR","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/fda-grants-additional-exclusivity-for-accrufer/9420124","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"31ggjTAmjjqDskaD1W0acx03UfJFHQAEmcN81JJolek2rTU6wWdJNaah281FAOLWXF6dwLcUeJRIv7GOxeOZCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-01-30","event_type":"corporate_action","title":"Total Voting Rights","rns_category":"Total Voting Rights","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/total-voting-rights/9395061","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"butQPDHE32el9qj5U8w5q6uW9NizHpQ3xLmod8xQXGpA8t1kEZ9BC7GflJxpLheQw9u-QOVdmSGFWcI4T_NPCg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-01-30","event_type":"regulatory_announcement","title":"Approval for ACCRUFeR in China expected in Q1 2026","rns_category":"Approval for ACCRUFeR in China expected in Q1 2026","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/approval-for-accrufer-in-china-expected-in-q1-2026/9394853","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"8f0FRY0Mk8hBs1YK0ern7whA7Ywnwg3OJ-OBZynkRslhdpAVXhjUyF0UCV6rYWbXQrQ3qIFbmYyZP4mX1DIpCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-01-29","event_type":"ch_capital","title":"capital allotment shares — 2026-01-28","ch_filing_type":"capital","source":"Companies House","url":"https://find-and-update.company-information.service.gov.uk/company/09761509/filing-history/MzUwMjIxNjc5M2FkaXF6a2N4/document?format=pdf&download=0","read_by":"Companies House REST API (filing history)","detail":"form SH01; category capital","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"foEL9eX4YatkGqgSATa2CpN64wTkNkozeVeCnQYADpSp1ZkbhszkRxMOWNZmKnb7WRz2XFNxM7ZS-GMXXM6vDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-01-27","event_type":"ch_capital","title":"capital allotment shares — 2025-12-29","ch_filing_type":"capital","source":"Companies House","url":"https://find-and-update.company-information.service.gov.uk/company/09761509/filing-history/MzUwMTY0NzkwMmFkaXF6a2N4/document?format=pdf&download=0","read_by":"Companies House REST API (filing history)","detail":"form SH01; category capital","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"CWYxBVSTQAQAPqWLHXOLPZAxGiPq16ela-OKoNh3yZyHo4ilKSr9xzfKUwNgmS5V92wFatufZ-DQIi0UQDtwCA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-01-21","event_type":"financial_statement","title":"Q4 2025 Trading Update","rns_category":"Q4 2025 Trading Update","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/q4-2025-trading-update/9370883","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"3IsCAhM5a8iby96rqCzY8UImv_PenKcxS-e5-otx-XjFeE21MBiNpqJSci0tJfb1mKQoMnKPZTkkX6jGEhqtBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-01-02","event_type":"corporate_action","title":"Block listing 6 Monthly Return","rns_category":"Block listing 6 Monthly Return","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/block-listing-6-monthly-return/9330129","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"UFrPpa_0l0w0WmTj5zNHtv4wi1bzo2d25FOR3bUAL1IJPKAFeQkheHWjqmkBpaNh-4SFNgYL0EIVlZiSDE9sCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2026-01-02","event_type":"corporate_action","title":"Total Voting Rights","rns_category":"Total Voting Rights","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/total-voting-rights/9328666","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"qArSEW_uSSeMb3b0gvdVbbsa5HfuuVDR9UOHekUQXZ17EbLtc310N20YIXZ8lf4luzuQEPBJBGBGLLtEUvK1Dw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2025-12-22","event_type":"regulatory_announcement","title":"FDA approves extension for ACCRUFeR®","rns_category":"FDA approves extension for ACCRUFeR®","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/fda-approves-extension-for-accrufer-/9311326","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"zbM_FtyrTFWQASzugK5vGE-ODLwuPiS_YD6C3GzLsWq5MyPbfQCT-IDxT4FjaJ0CmRyJStNwY9pOCG9Th2BjBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2025-12-18","event_type":"corporate_action","title":"Block Listing Application","rns_category":"Block Listing Application","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/block-listing-application/9305749","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"kmjINeONUPsmdVl3ycA2Khehk62nqys9Z0D7TwL8kYBgVHHEDaODCEfbTWRwr2tz5N9uXHYjSoRepPxHPrrUBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2025-12-17","event_type":"ch_capital","title":"capital allotment shares — 2025-12-04","ch_filing_type":"capital","source":"Companies House","url":"https://find-and-update.company-information.service.gov.uk/company/09761509/filing-history/MzQ5NDk5NjAzMmFkaXF6a2N4/document?format=pdf&download=0","read_by":"Companies House REST API (filing history)","detail":"form SH01; category capital","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"JHPlfEzgwfvg5jZNYGVZiDh0WTj7jjbWExEJaeDaGujKwfO5tSyx3XABA1hYQJ3uZplYbGOAMp4HuqjRH4hkBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2025-12-11","event_type":"regulatory_announcement","title":"Shield Wins Gold at Titan Branding Awards","rns_category":"Shield Wins Gold at Titan Branding Awards","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/shield-wins-gold-at-titan-branding-awards/9289276","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"NEggI9Dyf0PNimT0aHqdX8MlFiLrsMLqIExa7zU5BkdCNjf31dZVVz-dMmnTJKme3G1YiyYINFRAk0M5JKACDg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2025-12-03","event_type":"regulatory_announcement","title":"Amends Senior Secured Debt Financing","rns_category":"Amends Senior Secured Debt Financing","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/amends-senior-secured-debt-financing-/9272076","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"VXvmtC9vxqaTzTM1EizIieLmUbs8utz6MHocJygv2Zc1M54wTDojLVu7MtdRVzbqWNhtj8-5DAAPkNUL0XG_BA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2025-11-14","event_type":"regulatory_announcement","title":"Initiation of a Phase II Clinical Trial in Japan","rns_category":"Initiation of a Phase II Clinical Trial in Japan","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/initiation-of-a-phase-ii-clinical-trial-in-japan/9233224","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"EboR2e1m_qIgSga3FZ_ARNYGQezTfGgQUOf1FUnVGg50chGn_J6Haw2d-hLiEo9HsXIxFiPjriVQdjk7hnbADQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2025-11-11","event_type":"regulatory_announcement","title":"ACCRUFeR Pediatric PK Results to be Presented","rns_category":"ACCRUFeR Pediatric PK Results to be Presented","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/accrufer-pediatric-pk-results-to-be-presented-/9225029","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"jltkRR7fUEGkGhtMGTrf36WOuK0XASvIGskyKL-ina7xTBeOM6OYS8IAVcJo9F7SwgJ8oUDFl6zoH9TYKDekCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2025-11-07","event_type":"regulatory_announcement","title":"ACCRUFeR receives Authorisation by Korean Ministry","rns_category":"ACCRUFeR receives Authorisation by Korean Ministry","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/accrufer-receives-authorisation-by-korean-ministry/9218647","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"g-fTESkdQCUlV-u3xKvDeuut28svP8_JCc1xa_T1M8Ulowbd2mptKwAodabM9wBnRIqolesZV0UzG5igPtl3Cw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2025-10-23","event_type":"financial_statement","title":"Q3 2025 Trading Update","rns_category":"Q3 2025 Trading Update","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/q3-2025-trading-update-/9188390","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"tUAdms3WPnPv5BNNSYR44ZcKVkNHt-b6yY7Pce2PlC4OFgvflO1nW-UCXCHc4sZojEXdPLnP7VgqUILKQKTwCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2025-10-14","event_type":"regulatory_announcement","title":"Grant of Share Options to Chief Executive Officer","rns_category":"Grant of Share Options to Chief Executive Officer","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/grant-of-share-options-to-chief-executive-officer/9170555","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"n3idWw_MUYGB4WofYzfENyIG-1iNOhRtZBpofXYzbrA1JGPoJp1wChqw50PdrDhCyIO3ZIkx5nW82XD4KJ-LCw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"uk-cm-kg/AIM/STX","date":"2025-10-01","event_type":"corporate_action","title":"Total Voting Rights","rns_category":"Total Voting Rights","wire":"RNS","source":"Regulatory announcement via Investegate (RNS)","url":"https://www.investegate.co.uk/announcement/rns/shield-therapeutics--stx/total-voting-rights/9142803","read_by":"investegate.co.uk company page (RNS mirror)","detail":"RIS source RNS","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"-r_aTo9m9F3X9KhCdVh5ojpIas4vS6x-sDjChqXDcDcsAVU2rOoyhURPScAa_bA6Yz-RYKu-DhgNTc6vA7aTCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}